Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX013
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Janex International, Inc. (NASDAQ: JANX) | Delayed: 16.81 -0.12 (0.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.93 | 52 Week High | $0.01 | |||
| Open | $16.88 | 52 Week Low | $0.00 | |||
| Day High | $17.26 | P/E | N/A | |||
| Day Low | $16.65 | EPS | $0.00 | |||
| Volume | 91,903 | |||||
